Minoseg Orvoscsoport Kft.

Minoseg Orvoscsoport Kft. in Veszprém focuses on nutritional and metabolic diseases, specifically targeting disorders of elevated blood fats such as hypertriglyceridemia, its severe variant, and related conditions. The ongoing studies aim to assess a new RNA‑based therapy, plozasiran, for its ability to lower fasting serum triglyceride levels and to confirm its safety over extended use.

• Evaluation of plozasiran’s efficacy in reducing triglyceride concentrations
• Assessment of treatment impact on severe hypertriglyceridemia patients
• Long‑term safety monitoring of the investigational therapy

With three active trials and two investigators, the hospital contributes valuable data to the European research community on managing lipid disorders.